International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2022 - Volume 26, Number 6
View All Articles in Issue

Page(s): 513

Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V, Allen, Jr., PhD, RPh, formulation, granisetron hydrochloride, vomiting, nausea, emesis, antiemetic agent, type 3 serotonergic receptor inhibitor, serotonin 5-HT3 receptor antagonist

Related Categories: CANCER AND AIDS, FORMULATIONS, GASTROENTEROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Nov/Dec 2022 Pg. 513
Granisetron Hydrochloride 0.2-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 419
Granisetron 1-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2013 Pg. 66
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly	Jan/Feb 2018 Pg. 86-94
Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1) Allen Loyd V Jr	Sep/Oct 2019 Pg. 413
Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus Allen Loyd V Jr	Jan/Feb 2023 Pg. 53
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Granisetron 0.05-mg/mL Oral Suspension Allen Loyd V Jr	May/Jun 2006 Pg. 222
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Wu George, Yeung Stanley, Chen Frank	Jan/Feb 2017 Pg. 76-82
Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Allen Loyd V Jr	Mar/Apr 2021 Pg. 144
Ondansetron Hydrochloride 2-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2012 Pg. 339
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Trissel Lawrence A, Xu Quanyun A	May/Jun 2005 Pg. 238-241
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Wu George, Powers Dan, Yeung Stanley, Chen Frank	Jan/Feb 2018 Pg. 76-85
Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet Allen Loyd V Jr	May/Jun 2019 Pg. 236
Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension Allen Loyd V Jr	Sep/Oct 2018 Pg. 411
Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	Jan/Feb 2022 Pg. 56
Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 58
Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions Allen Loyd V Jr	Nov/Dec 2018 Pg. 496
Return to Top